Molecular pathogenesis of thyroid nodules and cancer

被引:41
作者
Moretti, F
Nanni, S
Pontecorvi, A
机构
[1] CNR, Inst Expt Med, I-00185 Rome, Italy
[2] Catholic Univ, Inst Med Pathol, Rome, Italy
[3] Regina Elena Inst Canc Res, Mol Oncogenesis Lab, I-00158 Rome, Italy
关键词
thyroid nodules; thyroid cancer; oncogenes; oncosuppressors; growth factors;
D O I
10.1053/beem.2000.0101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumours derived from the thyroid follicular epithelium represent an informative model for understanding the molecular pathogenesis of multistage tumourigenesis, which is the prevailing theory on cancer development and progression nowadays. The early stages of thyroid tumour development appear to be the consequence of the activation or 'de novo' expression of several proto-oncogenes or growth factor receptors, such as ras, ret, NTRK, met, gsp and the thyrotropin (TSH) receptor. Alterations in the expression pattern of these genes are associated with the development of differentiated neoplasms, ranging from benign toxic adenomas (gsp and TSH receptor), to follicular (ros) and papillary (ret/PTC, NTRK, met) carcinomas. They may all be considered to be early events of thyroid cell transformation and, for some, experimental evidence derived from gene transfer studies supports this hypothesis. Alterations in tumour suppressor genes (p53, Rb) are associated instead with the most aggressive and poorly differentiated forms of thyroid cancer, indicating that, in the thyroid tumourigenic process, they represent late genetic events, Specific environmental factors (iodine deficiency, ionizing radiations) have been shown to play a crucial role in promoting the development of thyroid cancer, influencing both its genotypic and phenotypic features. Interestingly, a high percentage of genetic lesions causing thyroid cancer originate from gene rearrangements and chromosomal translocations (ret/PTC, NTRK, Pax-8/PPAR gamma) a finding which, being a rare event in most epithelial tumours, makes the molecular pathogenesis of thyroid cancer unique. The uninterrupted flow of information on the molecular genetics of thyroid nodules and cancer will broaden the correlation between genotype and phenotype and will also provide important information for the development of more accurate preoperative diagnostic tools and more efficient treatment choices for the different forms of thyroid cancer.
引用
收藏
页码:517 / 539
页数:23
相关论文
共 207 条
[1]   Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines [J].
Ain, KB ;
Taylor, KD ;
Tofiq, S ;
Venkataraman, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1857-1862
[2]   CLONALITY OF THYROID-NODULES IN SPORADIC GOITER [J].
APEL, RL ;
EZZAT, S ;
BAPAT, BV ;
PAN, N ;
LIVOLSI, VA ;
ASA, SL .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1995, 4 (02) :113-121
[3]   EFFECTS OF TRANSFORMING GROWTH-FACTOR-ALPHA (TGF-ALPHA) ON DNA-SYNTHESIS AND THYROTROPIN-INDUCED IODINE-METABOLISM IN CULTURED PORCINE THYROID-CELLS [J].
ARAI, M ;
TSUSHIMA, T ;
ISOZAKI, O ;
DEMURA, H ;
SHIZUME, K ;
EMOTO, N ;
MIYAKAWA, M ;
NOZOE, Y ;
MURAKAMI, H ;
OHMURA, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (02) :242-248
[4]   THE TRK FAMILY OF TYROSINE PROTEIN-KINASE RECEPTORS [J].
BARBACID, M ;
LAMBALLE, F ;
PULIDO, D ;
KLEIN, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :115-127
[5]   Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: Search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene [J].
Bartolone, L ;
Vermiglio, F ;
Finocchiaro, MD ;
Violi, MA ;
French, D ;
Pontecorvi, A ;
Trimarchi, F ;
Benvenga, S .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (10) :680-687
[6]   EXPRESSION OF P21 RAS PROTEIN AS A PROGNOSTIC FACTOR IN PAPILLARY THYROID-CANCER [J].
BASOLO, F ;
PINCHERA, A ;
FUGAZZOLA, L ;
FONTANINI, G ;
ELISEI, R ;
ROMEI, C ;
PACINI, F .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (02) :171-174
[7]   N-ras mutation in poorly differentiated thyroid carcinomas:: Correlation with bone metastases and inverse correlation to thyroglobulin expression [J].
Basolo, F ;
Pisaturo, F ;
Pollina, LE ;
Fontanini, G ;
Elisei, R ;
Molinaro, E ;
Iacconi, P ;
Miccoli, P ;
Pacini, F .
THYROID, 2000, 10 (01) :19-23
[8]   Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo [J].
Battista, S ;
de Nigris, F ;
Fedele, M ;
Chiappetta, G ;
Scala, S ;
Vallone, D ;
Pierantoni, GM ;
Megar, T ;
Santoro, M ;
Viglietto, G ;
Verde, P ;
Fusco, A .
ONCOGENE, 1998, 17 (03) :377-385
[9]   Induction of apoptosis in porcine thyroid follicles by transforming growth factor β1 and epidermal growth factor [J].
Bechtner, G ;
Fröschl, H ;
Sachse, A ;
Schopohl, D ;
Gärtner, R .
BIOCHIMIE, 1999, 81 (04) :315-320
[10]  
Beimfohr C, 1999, INT J CANCER, V80, P842, DOI 10.1002/(SICI)1097-0215(19990315)80:6<842::AID-IJC7>3.3.CO